Physician profile
Steven J Morgan
NPI 1427068287
$200,444.22
in general payments reported to CMS, 2019-2025
11 companies · $69K in 2025
The $69K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $15K · 2021: $5,987 · 2022: $1,279 · 2023: $32K · 2024: $58K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $142K · Consulting Fee: $9,216 · Honoraria: $6,000 · Food and Beverage: $1,267 · Travel and Lodging: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $141,967.62 |
| Consulting Fee | $9,215.69 |
| Honoraria | $6,000.00 |
| Food and Beverage | $1,266.73 |
| Travel and Lodging | $684.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $172,481.25 | 2019-2025 | Acumed, Acumed |
| Illuminoss Medical, INC. | $17,399.52 | 2020-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Synthes USA Products LLC | $7,514.13 | 2020 | |
| Medical Device Business Services, INC. | $1,125.00 | 2020 | |
| Depuy Synthes Sales INC. | $601.66 | 2020-2025 | Na, Tfn-Advance, Motoband |
| Medacta USA, INC. | $505.09 | 2019-2025 | M-Vizion |
| Curvafix, INC. | $500.00 | 2024 | Curvafix Im Implant |
| Si-Bone, INC. | $139.92 | 2022 | |
| Globus Medical, INC. | $89.18 | 2023 | Proximal Tibia Plate |
| Arthrex, INC. | $61.34 | 2025 | |
| Stryker Corporation | $27.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.